Bringing together specialised biotechs/pharmas, government, payers, investors & patient groups in one platform, this event offers a unique opportunity to increase brand visibility amongst the rare disease industry in Asia.
Position yourself as a leader by delivering a keynote presentation or securing an exhibition booth.
"It is the only pan-indication rare disease meeting in Asia and a great place to meet potential clients and collaborators."
A*S.T.A.R. Singapore Immunology Network A.F.T. Orphan Actelion Actelion Pharmaceuticals Alexion Pharmaceuticals Australasia Pty Ltd Alnylam Pharmaceuticals AMICULUM Amiculum Consulting Asklepion Pharmaceuticals LLC AstraZeneca ASUS Computer International Australian Government AxxessBio Pte Ltd B.T.I Baxalta Baxalta Singapore Pte Ltd Bayer Bayer Healthcare Beijing Genome Institute Beijing Yuan Tang Institute Of Gene Science Biogen Idec BioMarin BioMarin Pharmaceutical Inc. Bioneur Bioprocessing Technology Institute Singapore Biovalence S/B Boston Consulting Group Bristol-Myers Squibb C.M.I.C. Holdings Co Ltd Carcinoid & Neuroendocrine Tumor Society Centogene India Pvt Ltd Chinese Organization for Rare Disorders Cimbria As Clinical Nutrition Research Centre NUS Clinigen Group plc Club Rainbow Comradis Cote Orphan Consulting Cytonet Gmbh DEBRA DEBRA International Dipharma SA Dipharma SA Edimer Pharmaceuticals Inc Eisai Clinical Research Singapore Pte Ltd Eisai Pharmaceuticals India Pte. Eli Lilly Emerge Health Pty Ltd Equisnzaroo Esthelis Clinic Excelsior Biopharma Inc. Food and Drug Administration Fuld & Company Genome Institute of Singapore Genzyme Genzyme A Sanofi Company Genzyme Korea Genzyme Singapore Pte Ltd GlaxoSmithKline GNI Ltd. and Shanghai Genomics H.A.E.i International Patient Organization for C1 Hong Kong Mucopolysaccharidoses & Rare Diseases Mutual Aid Group HongKong Polytechnic University Institute for Optimizing Health Outcomes Institute of Medical Biology, A*STAR Integrated Development Associates J.C.R. Pharmaceuticals Co Ltd King Baudouin Foundation Korea Organization for Rare Diseases Korea Orphan Drug Center Licensing & Development LINK Healthcare LSD Support Society Malaysia Lysosomal Diseases Association Malaysia Metabolic Society Malaysian Rare Disorders Society Medicines Australia Merck Sharp & Dohme Ministry of Health Ministry of Health Malaysia Pharmaceutical Services Division Muscular Dystrophy Foundation India Nanolek LLC National Health Insurance Administration, Ministry of Health and Welfare National Institutes of Health National University Of Singapore New Zealand Organisation for Rare Disorders Nobelpharma Co., Ltd. Novartis Novartis Pharmaceuticals (HK) Limited Novena Cancer Centre Orphan Druganaut Blog Orphan Europe Orphan Trust Japan Co., Ltd. Osaka University P.B.L. Solutions Pfizer Private Limited Pharm-D Phebra Pty Ltd Plus One HealthCare Consulting Project Manager PTC Therapeutics Quintiles East Asia Pte Ltd Rare Disorders Society (Singapore) Rare Genomic Asia Rare Genomics Institute ReGenXBio Royal Holloway, University of London Sanofi Sanofi-Aventis Singapore Pte Ltd SGPharma Pvt. Ltd. Shionogi Shire Shire AG Shire Australia Shire Hgt Shire Pharmaceuticals Inc Shire Singapore Pte Ltd Singapore Immunology Network (SIgN) Singapore Immunology Network, ASTAR Social Security Association Society of Rare Disorders (Japan) Stiefel, a GSK company Supporting Organization for Patients with Rare Diseases (SORD) SymBio Pharmaceuticals Limited Taho Pharmaceuticals Taiwan Foundation for Rare Diseases (TFRD) Tanner Pharma Group Thailand Fda Toho Orphan Reliance Transmedic Healthcare Transmedic Pte Ltd Tunghai University / Chung Gung University / Toastmasters International (NGO) U.S. Hereditary Angioedema Association Universiti Kebangsaan Malaysia Valentech Pharma Valiant Biopharma Sdn Bhd